<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of <z:e sem="disease" ids="C0268450" disease_type="Disease or Syndrome" abbrv="">Gitelman syndrome</z:e> (GS) in a dizygotic twin who presented at 12 years of age with <z:hpo ids='HP_0001510'>growth delay</z:hpo>, metabolic <z:hpo ids='HP_0001948'>alkalosis</z:hpo>, <z:hpo ids='HP_0002917'>hypomagnesemia</z:hpo> and <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> with inappropriate kaliuresis, and idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> with bilateral <z:hpo ids='HP_0001085'>papilledema</z:hpo> (<z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The patient, her twin sister, and her mother also presented with cerebral cavernous malformations </plain></SENT>
<SENT sid="2" pm="."><plain>Based on the early <z:hpo ids='HP_0003674'>onset</z:hpo> and normocalciuria, <z:e sem="disease" ids="C0004775" disease_type="Disease or Syndrome" abbrv="">Bartter syndrome</z:e> was diagnosed first </plain></SENT>
<SENT sid="3" pm="."><plain>However, mutation analysis showed that the proband is a compound heterozygote for 2 mutations in SLC12A3: a substitution of serine by leucine at amino acid position 555 (p.Ser555Leu) and a novel <z:chebi fb="1" ids="16235">guanine</z:chebi> to <z:chebi fb="1" ids="16040">cytosine</z:chebi> transition at the 5' splice site of intron 22 (c.2633+1G&gt;C), providing the molecular diagnosis of GS </plain></SENT>
<SENT sid="4" pm="."><plain>These mutations were not detected in 200 <z:mpath ids='MPATH_458'>normal</z:mpath> chromosomes and cosegregated within the family </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of complementary DNA showed that the heterozygous nucleotide change c.2633+1G&gt;C caused the appearance of 2 RNA molecules, 1 <z:mpath ids='MPATH_458'>normal</z:mpath> transcript and 1 skipping the entire exon 22 (r.2521_2634del) </plain></SENT>
<SENT sid="6" pm="."><plain>Supplementation with <z:chebi fb="120" ids="26216">potassium</z:chebi> and <z:chebi fb="131" ids="25107">magnesium</z:chebi> improved clinical symptoms and resulted in catch-up growth, but vision remained impaired </plain></SENT>
<SENT sid="7" pm="."><plain>Three similar associations of <z:e sem="disease" ids="C0004775" disease_type="Disease or Syndrome" abbrv="">Bartter syndrome</z:e>/GS with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> were found in the literature, suggesting that electrolyte abnormalities and <z:e sem="disease" ids="C0271728" disease_type="Disease or Syndrome" abbrv="">secondary aldosteronism</z:e> may have a role in idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>This study provides further evidence for the phenotypical <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of GS and its association with severe manifestations in children </plain></SENT>
<SENT sid="9" pm="."><plain>It also shows the independent segregation of familial cavernomatosis and GS </plain></SENT>
</text></document>